Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Other hematologic neoplasm × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 788 Precursor Cell Lymphoblastic Leukemia-Lymphoma 468 Hematologic Neoplasms 411 Leukemia, Lymphocytic, Chronic, B-Cell 355 Leukemia 314 Myelodysplastic Syndromes 290 Lymphoma 189 Lymphoma, Non-Hodgkin 167 Multiple Myeloma 128 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 127 Recurrence 125 Neoplasms 117 Leukemia, Myelomonocytic, Chronic 107 Burkitt Lymphoma 88 Lymphoma, Follicular 86 Lymphoma, Mantle-Cell 85 Lymphoma, Large B-Cell, Diffuse 85 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 77 Myeloproliferative Disorders 74 Leukemia, Biphenotypic, Acute 71 Lymphoma, B-Cell, Marginal Zone 70 Hodgkin Disease 70 Lymphoma, B-Cell 62 Primary Myelofibrosis 45 Waldenstrom Macroglobulinemia 42 Leukemia, B-Cell 42 Anemia, Refractory, with Excess of Blasts 41 Leukemia, Myeloid, Chronic-Phase 36 Neoplasm, Residual 34 Hematologic Diseases 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡